Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 614

1.

Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative Stress.

González-Blázquez R, Somoza B, Gil-Ortega M, Martín Ramos M, Ramiro-Cortijo D, Vega-Martín E, Schulz A, Ruilope LM, Kolkhof P, Kreutz R, Fernández-Alfonso MS.

Front Pharmacol. 2018 Oct 9;9:1131. doi: 10.3389/fphar.2018.01131. eCollection 2018.

2.

Prognostic Value of Masked Uncontrolled Hypertension.

Pierdomenico SD, Pierdomenico AM, Coccina F, Clement DL, De Buyzere ML, De Bacquer DA, Ben-Dov IZ, Vongpatanasin W, Banegas JR, Ruilope LM, Thijs L, Staessen JA.

Hypertension. 2018 Oct;72(4):862-869. doi: 10.1161/HYPERTENSIONAHA.118.11499.

PMID:
30354717
3.

Ambulatory Blood Pressure and Mortality.

Banegas JR, Ruilope LM, Williams B.

N Engl J Med. 2018 Sep 27;379(13):1287-8. doi: 10.1056/NEJMc1809851. No abstract available.

4.

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.

Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee.

Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26.

PMID:
30158069
5.

Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors.

Fiuza-Luces C, Santos-Lozano A, Joyner M, Carrera-Bastos P, Picazo O, Zugaza JL, Izquierdo M, Ruilope LM, Lucia A.

Nat Rev Cardiol. 2018 Aug 16. doi: 10.1038/s41569-018-0065-1. [Epub ahead of print] Review.

PMID:
30115967
6.

The epidemiological magnitude of white-coat hypertension and masked hypertension in Africa.

Banegas JR, Ruilope LM.

J Clin Hypertens (Greenwich). 2018 Jul 9. doi: 10.1111/jch.13328. [Epub ahead of print] No abstract available.

7.

Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors.

Gorostidi M, Sánchez-Martínez M, Ruilope LM, Graciani A, de la Cruz JJ, Santamaría R, Del Pino MD, Guallar-Castillón P, de Álvaro F, Rodríguez-Artalejo F, Banegas JR.

Nefrologia. 2018 Jun 18. pii: S0211-6995(18)30075-4. doi: 10.1016/j.nefro.2018.04.004. [Epub ahead of print] English, Spanish.

8.

[Mortality study from the Spanish Registry of ABPM. An appeal for the transition of ABPM to clinical practice].

Banegas JR, Ruilope LM.

Hipertens Riesgo Vasc. 2018 Jun 13. pii: S1889-1837(18)30063-1. doi: 10.1016/j.hipert.2018.05.002. [Epub ahead of print] Spanish. No abstract available.

PMID:
29908924
9.

Prevalence of Masked Hypertension in Untreated and Treated Patients With Office Blood Pressure Below 130/80 mm Hg.

de la Sierra A, Banegas JR, Vinyoles E, Segura J, Gorostidi M, de la Cruz JJ, Ruilope LM.

Circulation. 2018 Jun 12;137(24):2651-2653. doi: 10.1161/CIRCULATIONAHA.118.034619. Epub 2018 Apr 30. No abstract available.

PMID:
29712713
10.

[Spanish Society of Hypertension position statement on the 2017 ACC/AHA hypertension guidelines].

Gijón-Conde T, Gorostidi M, Camafort M, Abad-Cardiel M, Martín-Rioboo E, Morales-Olivas F, Vinyoles E, Armario P, Banegas JR, Coca A, de la Sierra A, Martell-Claros N, Redón J, Ruilope LM, Segura J.

Hipertens Riesgo Vasc. 2018 Apr 24. pii: S1889-1837(18)30033-3. doi: 10.1016/j.hipert.2018.04.001. [Epub ahead of print] Spanish.

11.

Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality.

Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, Ruiz-Hurtado G, Segura J, Rodríguez-Artalejo F, Williams B.

N Engl J Med. 2018 Apr 19;378(16):1509-1520. doi: 10.1056/NEJMoa1712231.

12.

Translational science in albuminuria: a new view of de novo albuminuria under chronic RAS suppression.

Baldan-Martin M, Rodríguez-Sánchez E, González-Calero L, Ruilope LM, Alvarez-Llamas G, Barderas MG, Ruiz-Hurtado G.

Clin Sci (Lond). 2018 Apr 6;132(7):739-758. doi: 10.1042/CS20180097. Print 2018 Apr 16. Review.

PMID:
29626149
13.

White-coat UnControlled Hypertension, Masked UnControlled Hypertension, and True UnControlled Hypertension, phonetic and mnemonic terms for treated hypertension phenotypes.

Banegas JR, Ruilope LM, Williams B.

J Hypertens. 2018 Feb;36(2):446-447. doi: 10.1097/HJH.0000000000001615. No abstract available.

PMID:
29611838
14.

Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension.

de la Sierra A, Armario P, Oliveras A, Banegas JR, Gorostidi M, Vinyoles E, de la Cruz JJ, Segura J, Ruilope LM.

J Hypertens. 2018 Jul;36(7):1563-1570. doi: 10.1097/HJH.0000000000001729.

PMID:
29601411
15.

Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals.

Baldan-Martin M, Lopez JA, Corbacho-Alonso N, Martinez PJ, Rodriguez-Sanchez E, Mourino-Alvarez L, Sastre-Oliva T, Martin-Rojas T, Rincón R, Calvo E, Vazquez J, Vivanco F, Padial LR, Alvarez-Llamas G, Ruiz-Hurtado G, Ruilope LM, Barderas MG.

Sci Rep. 2018 Mar 19;8(1):4802. doi: 10.1038/s41598-018-23037-7.

16.

Author Correction: Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Martin-Lorenzo M, Gonzalez-Calero L, Martinez PJ, Baldan-Martin M, Lopez JA, Ruiz-Hurtado G, de la Cuesta F, Segura J, Vazquez J, Vivanco F, Barderas MG, Ruilope LM, Alvarez-Llamas G.

Sci Rep. 2018 Mar 2;8(1):4154. doi: 10.1038/s41598-018-22185-0.

17.

Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.

Sarafidis PA, Ruilope LM, Loutradis C, Gorostidi M, de la Sierra A, de la Cruz JJ, Vinyoles E, Divisón-Garrote JA, Segura J, Banegas JR.

J Hypertens. 2018 May;36(5):1076-1085. doi: 10.1097/HJH.0000000000001670.

PMID:
29465710
18.

The use of antihypertensive fixed combinations in clinical practice needs a reappraisal.

Ruilope LM, Banegas JR.

J Clin Hypertens (Greenwich). 2018 Apr;20(4):716-717. doi: 10.1111/jch.13244. Epub 2018 Feb 19. No abstract available.

19.

PTH, vitamin D, and the FGF-23-klotho axis and heart: Going beyond the confines of nephrology.

Navarro-García JA, Fernández-Velasco M, Delgado C, Delgado JF, Kuro-O M, Ruilope LM, Ruiz-Hurtado G.

Eur J Clin Invest. 2018 Apr;48(4). doi: 10.1111/eci.12902. Epub 2018 Feb 21. Review.

PMID:
29394451
20.

Obesity and hypertension in Latin America: Current perspectives.

Ruilope LM, Nunes Filho ACB, Nadruz W Jr, Rodríguez Rosales FF, Verdejo-Paris J.

Hipertens Riesgo Vasc. 2018 Apr - Jun;35(2):70-76. doi: 10.1016/j.hipert.2017.12.004. Epub 2018 Feb 1.

PMID:
29361428

Supplemental Content

Loading ...
Support Center